Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.

Author: BrüningRoland, FerrucciPier Francesco, KirsteinMartha M, MannsMichael P, MarquardtSteffen, PrevooWarner, RadeleffBoris, TrillaudHervé, TselikasLambros, VicenteEmilio, VogelArndt, WackerFrank K, WiggermannPhilipp, ZeileMartin

Paper Details 
Original Abstract of the Article :
Cholangiocarcinoma is the second most common primary liver tumour with a poor overall prognosis. Percutaneous hepatic perfusion (PHP) is a directed therapy for primary and secondary liver malignancies, and its efficacy and safety have been shown in different entities. The purpose of this study was t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00330-018-5729-z

データ提供:米国国立医学図書館(NLM)

Percutaneous Hepatic Perfusion: A Targeted Approach to Cholangiocarcinoma

Cholangiocarcinoma, a type of liver cancer, presents a significant challenge due to its poor prognosis. This research investigates the safety and efficacy of percutaneous hepatic perfusion (PHP) in treating unresectable intrahepatic cholangiocarcinoma (iCCA). PHP is a targeted therapy that delivers chemotherapy directly to the liver, aiming to enhance the treatment effect and minimize systemic side effects. The study highlights the potential of PHP as a safe and effective treatment option for patients with iCCA. This research offers hope for patients facing this challenging form of cancer, providing a potential avenue for targeted and effective treatment.

PHP: A Focused Approach for Liver Cancer

PHP, like a desert oasis, offers a targeted and focused solution to combat iCCA. The study confirms its safety and efficacy, demonstrating the potential of this technique to improve the lives of patients with this devastating disease. The use of PHP in iCCA represents a promising step forward in the treatment of liver cancer, offering a personalized approach that aims to maximize treatment effects while minimizing systemic side effects.

A Light in the Desert: PHP for Liver Cancer

The findings of this study illuminate a potential path for treating iCCA. This focused therapy offers hope to patients battling this challenging disease. PHP, with its targeted delivery of chemotherapy, could provide a better chance of achieving successful treatment outcomes and improving the overall quality of life for patients with iCCA. It is crucial to continue research in this area to further optimize PHP and explore its potential as a long-term solution for iCCA.

Dr.Camel's Conclusion

The vast desert of liver cancer research is constantly evolving, and PHP offers a refreshing oasis. This targeted therapy holds promise for patients with iCCA, providing a focused and effective approach. As with any oasis, it is essential to explore and understand its limitations and potential, ensuring its continued effectiveness in treating this challenging disease.

Date :
  1. Date Completed 2019-05-09
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

30255257

DOI: Digital Object Identifier

10.1007/s00330-018-5729-z

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.